FDA and other Public Health Service agencies believe that the risk of contamination of any US licensed vaccine with the BSE agent is remote and theoretical. FDA asked a special joint meeting of the Transmissible Spongiform Encephalopathy and the Vaccines and related Biological products Advisory Committees to review the available vaccine risk and benefit information. This joint committee concluded that the substantial risk of disease due to not vaccinating children far outweigh the theoretical risk posed by vaccines that have a remote chance of containing the BSE agent. Com Web Ring. All rights reserved.
Trademarks belong to their respective owners.
By using this web site, including Sales and Messageboards , you are agreeing to the Terms of Use . While the information published on this site is believed to be accurate, it is not intended to substitute for professional medical advice. If you have questions or concerns regarding your health or that of your baby, seek assistance directly from a qualified health care provider.